Expres2ion Biotechnologies ApS

Expres2ion Biotechnologies ApS is an SME in Horsholm, Denmark that has taken part in 7 EU-funded projects since 2013, receiving €6.3M in EU funding.

EU funding received€6.3M
EU projects7
As coordinator0
Running now2
First EU project2013
Latest project2025
CountryDenmark
EU registration (PIC)954194433
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Expres2ion Biotechnologies ApS's own share of each project, not the project's full budget.

  • Horizon Europe€4.3M · 2 projects
  • Horizon 2020€1.0M · 4 projects
  • FP7 (2007 to 2013)€997k · 1 project

Projects

7 EU-funded projects, newest first. Each links to the official record.

  • MVC-2GPartner

    Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €50ktheir share
  • VICI-DISEASEPartner

    PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINE

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €4.3Mtheir share
  • Prevent-nCoVPartner

    Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €161ktheir share
  • INDIGOPartner

    Effective and Affordable Flu Vaccines for the World

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €400ktheir share
  • MultiViVaxPartner

    Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €25ktheir share
  • OptiMalVaxPartner

    Optimizing a deployable high efficacy malaria vaccine

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €445ktheir share
  • PLACMALVACPartner

    Clinical development of a VAR2CSA-based placental malaria vaccine

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €997ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • coronaviruses
  • embryology
  • immunisation
  • immunology
  • influenza
  • malaria
  • obstetrics
  • pandemics
  • proteins
  • toxicology
  • vaccines
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime